179 related articles for article (PubMed ID: 18301101)
1. Comparison of activation products and induced dose rates in different high-energy medical linear accelerators.
Fischer HW; Tabot B; Poppe B
Health Phys; 2008 Mar; 94(3):272-8. PubMed ID: 18301101
[TBL] [Abstract][Full Text] [Related]
2. Contribution of activation products to occupational exposure following treatment using high-energy photons in radiotherapy.
Petrović N; Krestić-Vesović J; Stojanović D; Ciraj-Bjelac O; Lazarević D; Kovacević M
Radiat Prot Dosimetry; 2011 Jan; 143(1):109-12. PubMed ID: 20947589
[TBL] [Abstract][Full Text] [Related]
3. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
[TBL] [Abstract][Full Text] [Related]
4. Health physics aspects of neutron activated components in a linear accelerator.
Guo S; Ziemer PL
Health Phys; 2004 May; 86(5 Suppl):S94-S102. PubMed ID: 15069298
[TBL] [Abstract][Full Text] [Related]
5. Remanent dose rates around the collimators of the LHC beam cleaning insertions.
Brugger M; Roesler S
Radiat Prot Dosimetry; 2005; 115(1-4):470-4. PubMed ID: 16381769
[TBL] [Abstract][Full Text] [Related]
6. Undesirable nuclear reactions and induced radioactivity as a result of the use of the high-energy therapeutic beams generated by medical linacs.
Konefal A; Polaczek-Grelik K; Zipper W
Radiat Prot Dosimetry; 2008; 128(2):133-45. PubMed ID: 17569692
[TBL] [Abstract][Full Text] [Related]
7. Induced radioactivity in CU targets produced by high-energy heavy ions and the corresponding estimated photon dose rates.
Yashima H; Uwamino Y; Sugita H; Ito S; Nakamura T; Fukumura A
Radiat Prot Dosimetry; 2004; 112(2):195-208. PubMed ID: 15280565
[TBL] [Abstract][Full Text] [Related]
8. Activation processes in a medical linear accelerator and spatial distribution of activation products.
Fischer HW; Tabot BE; Poppe B
Phys Med Biol; 2006 Dec; 51(24):N461-6. PubMed ID: 17148816
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of potential exposure risk for radiotherapy staff working with lineal accelerators].
Tofani A; Del Corona A; Manetti F
Radiol Med; 1999 Apr; 97(4):286-95. PubMed ID: 10414263
[TBL] [Abstract][Full Text] [Related]
10. DOSE AND GAMMA-RAY SPECTRA FROM NEUTRON-INDUCED RADIOACTIVITY IN MEDICAL LINEAR ACCELERATORS FOLLOWING HIGH-ENERGY TOTAL BODY IRRADIATION.
Keehan S; Taylor ML; Smith RL; Dunn L; Kron T; Franich RD
Radiat Prot Dosimetry; 2016 Dec; 172(4):327-332. PubMed ID: 26598738
[TBL] [Abstract][Full Text] [Related]
11. Induced radioactive nuclides of 10-MeV radiotherapy accelerators detected by using a portable HP-Ge survey meter.
Fujibuchi T; Obara S; Yamaguchi I; Oyama M; Watanabe H; Sakae T; Katoh K
Radiat Prot Dosimetry; 2012 Jan; 148(2):168-73. PubMed ID: 21317145
[TBL] [Abstract][Full Text] [Related]
12. Radiation protection aspects of a 4 MW target.
Agosteo S; Magistris M; Silari M
Radiat Prot Dosimetry; 2005; 115(1-4):465-9. PubMed ID: 16381768
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of air photoactivation at linear accelerators for radiotherapy.
Tana L; Ciolini R; Ciuffardi E; Romei C; d'Errico F
J Radiol Prot; 2015 Jun; 35(2):239-48. PubMed ID: 25760952
[TBL] [Abstract][Full Text] [Related]
14. Health physics aspects in treatment rooms after 18-MV X-ray irradiations.
Kalef-Ezra JA
Radiat Prot Dosimetry; 2011 Sep; 147(1-2):281-6. PubMed ID: 21979431
[TBL] [Abstract][Full Text] [Related]
15. Radiation protection system at the RIKEN RI beam factory.
Uwamino Y; Fujita S; Sakamoto H; Ito S; Fukunishi N; Yabutani T; Yamano T; Fukumura A
Radiat Prot Dosimetry; 2005; 115(1-4):279-83. PubMed ID: 16381729
[TBL] [Abstract][Full Text] [Related]
16. A comparison of different recombination methods in mixed radiation fields at high energy accelerators.
Zielczynski M; Golnik N; Gryzinski MA
Radiat Prot Dosimetry; 2007; 126(1-4):248-52. PubMed ID: 17575296
[TBL] [Abstract][Full Text] [Related]
17. High-level dosimetry at the demagnetization experiments of permanent magnets.
Lee HS; Qiu R; Hong S; Chung CW; Bizen T; Li J
Radiat Prot Dosimetry; 2007; 126(1-4):288-93. PubMed ID: 17575293
[TBL] [Abstract][Full Text] [Related]
18. [Activation of solid materials in a medical linear electron accelerator].
Ewen K; Lauber-Altmann I
Rontgenblatter; 1987 Jun; 40(6):185-90. PubMed ID: 3616427
[TBL] [Abstract][Full Text] [Related]
19. Radiation impact caused by activation of air from the future GSI accelerator facility fair.
Gutermuth F; Wildermuth H; Radon T; Fehrenbacher G
Radiat Prot Dosimetry; 2005; 115(1-4):437-40. PubMed ID: 16381762
[TBL] [Abstract][Full Text] [Related]
20. Exposure of medical personnel to radiation during radionuclide therapy practices.
Lancelot S; Guillet B; Sigrist S; Bourrelly M; Waultier S; Mundler O; Pisano P
Nucl Med Commun; 2008 Apr; 29(4):405-10. PubMed ID: 18317307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
